Literature DB >> 26173593

Advances in sentinel node dissection in prostate cancer from a technical perspective.

Cenk Acar1, Gijs H Kleinjan2,3, Nynke S van den Berg2,4, Esther Mk Wit4, Fijs Wb van Leeuwen2,4, Henk G van der Poel4.   

Abstract

The most important feature of sentinel node biopsy for prostate cancer procedure is that staging can be improved. Sentinel nodes might be found outside the extended pelvic lymph node dissection template what renders the sentinel node additive of extended pelvic lymph node dissection. At the same time, staging within the template can be further refined. We reviewed the literature regarding the sentinel node biopsy procedure for prostate cancer. PubMed and Embase were searched for all English-language publications from January 1999 to September 2014 by using the keywords as "prostate cancer" and "sentinel lymph node" plus "biopsy" "dissection" and/or "procedure." The present review discusses step-by-step sentinel node biopsy for prostate cancer. Topics of discussion are: (i) preoperative sentinel node mapping (tracers and imaging); (ii) intraoperative sentinel node identification (surgical procedure and outcome); and (iii) novelties to improve sentinel node identification (pre- and intraoperative approaches). Conventional sentinel node mapping is carried out after the injection of a (99m) Tc-based tracer and subsequent preoperative imaging; for example, lymphoscintigraphy and single-photon emission computed tomography/computed tomography. This approach allowed the detection of sentinel nodes outside the extended lymph node dissection template in 3.6-36% of men with intermediate- and high-risk prostate cancer. Hereby, an overall false negative rate of sentinel nodes was reported between 0% and 24.4%. To further refine the intraoperative sampling procedure, novel imaging methods such as fluorescence imaging have been introduced. Prospective randomized comparison studies are required to confirm the added benefit of sentinel template directed nodal dissection. A proper and obtainable end-point of such a study could be the number of removed positive nodes for carrying out nodal dissection with or without sentinel template directed dissection. Similarly, the clinical impact of novel imaging technologies requires further investigation.
© 2015 The Japanese Urological Association.

Entities:  

Keywords:  biopsy; indocyanine green; nuclear imaging; prostate cancer; sentinel lymph node

Mesh:

Substances:

Year:  2015        PMID: 26173593     DOI: 10.1111/iju.12863

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  11 in total

1.  Laparoscopic sentinel lymph node dissection in prostate cancer patients: the additional value depends on preoperative data.

Authors:  Caroline Rousseau; Thierry Rousseau; Cédric Mathieu; Jacques Lacoste; Eric Potiron; Geneviève Aillet; Pierre Nevoux; Georges Le Coguic; Loïc Campion; Françoise Kraeber-Bodéré
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-05-11       Impact factor: 9.236

Review 2.  Sentinel node biopsy and lymphatic mapping in penile and prostate cancer.

Authors:  H G van der Poel; P Meershoek; N Grivas; G KleinJan; F W B van Leeuwen; S Horenblas
Journal:  Urologe A       Date:  2017-01       Impact factor: 0.639

3.  Validation and head-to-head comparison of three nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended and/or sentinel lymph node dissection.

Authors:  Nikolaos Grivas; Esther Wit; Corinne Tillier; Erik van Muilekom; Floris Pos; Alexander Winter; Henk van der Poel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-05       Impact factor: 9.236

Review 4.  Beyond penile cancer, is there a role for sentinel node biopsy in urological malignancies?

Authors:  O R Brouwer; H G van der Poel; R F Bevers; E J van Gennep; S Horenblas
Journal:  Clin Transl Imaging       Date:  2016-07-04

5.  Updated Nomogram Incorporating Percentage of Positive Cores to Predict Probability of Lymph Node Invasion in Prostate Cancer Patients Undergoing Sentinel Lymph Node Dissection.

Authors:  Alexander Winter; Thomas Kneib; Clara Wasylow; Lena Reinhardt; Rolf-Peter Henke; Svenja Engels; Holger Gerullis; Friedhelm Wawroschek
Journal:  J Cancer       Date:  2017-08-22       Impact factor: 4.207

6.  An analysis of SPECT/CT non-visualization of sentinel lymph nodes in renal tumors.

Authors:  Teele Kuusk; Maarten L Donswijk; Renato A Valdés Olmos; Roderick E De Bruijn; Oscar R Brouwer; Kees Hendricksen; Simon Horenblas; Katarzyna Jóźwiak; Warner Prevoo; Henk G Van Der Poel; Bas W G Van Rhijn; Esther M Wit; Axel Bex
Journal:  EJNMMI Res       Date:  2018-12-03       Impact factor: 3.138

7.  Intraoperative assessment and postsurgical treatment of prostate cancer tumors using tumor-targeted nanoprobes.

Authors:  James Teh; Manisha Tripathi; Derek Reichel; Bien Sagong; Ricardo Montoya; Yi Zhang; Shawn Wagner; Rola Saouaf; Leland W K Chung; J Manuel Perez
Journal:  Nanotheranostics       Date:  2021-01-01

8.  Multimodal hybrid imaging agents for sentinel node mapping as a means to (re)connect nuclear medicine to advances made in robot-assisted surgery.

Authors:  Gijs H KleinJan; Nynke S van den Berg; Jeroen de Jong; Esther M Wit; Helene Thygessen; Erik Vegt; Henk G van der Poel; Fijs W B van Leeuwen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-01-15       Impact factor: 9.236

9.  Haute Couture or Ready-to-Wear? Tailored Pelvic Radiotherapy for Prostate Cancer Based on Individualized Sentinel Lymph Node Detection.

Authors:  Anne-Victoire Michaud; Benoit Samain; Ludovic Ferrer; Vincent Fleury; Mélanie Doré; Mathilde Colombié; Claire Dupuy; Emmanuel Rio; Valentine Guimas; Thierry Rousseau; Maelle Le Thiec; Grégory Delpon; Caroline Rousseau; Stéphane Supiot
Journal:  Cancers (Basel)       Date:  2020-04-10       Impact factor: 6.639

Review 10.  Pelvic lymph node dissection in high-risk prostate cancer.

Authors:  Luciano Haiquel; Xavier Cathelineau; Rafael Sanchez-Salas; Petr Macek; Fernando Secin
Journal:  Int Braz J Urol       Date:  2022 Jan-Feb       Impact factor: 1.541

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.